Cogent Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.About COGT
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.
CEOAndrew R. Robbins
CEOAndrew R. Robbins
Employees258
Employees258
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2014
Founded2014
Employees258
Employees258
COGT Key Statistics
Market cap5.86B
Market cap5.86B
Price-Earnings ratio-14.10
Price-Earnings ratio-14.10
Dividend yield—
Dividend yield—
Average volume1.77M
Average volume1.77M
High today$37.09
High today$37.09
Low today$35.57
Low today$35.57
Open price$36.15
Open price$36.15
Volume1.34M
Volume1.34M
52 Week high$43.73
52 Week high$43.73
52 Week low$3.72
52 Week low$3.72
Stock Snapshot
With a market cap of 5.86B, Cogent Biosciences(COGT) trades at $36.08. The stock has a price-to-earnings ratio of -14.10.
During the trading session on 2026-03-12, Cogent Biosciences(COGT) shares reached a daily high of $37.09 and a low of $35.57. At a current price of $36.08, the stock is +1.4% higher than the low and still -2.7% under the high.
Trading activity shows a volume of 1.34M, compared to an average daily volume of 1.77M.
The stock's 52-week range extends from a low of $3.72 to a high of $43.73.
The stock's 52-week range extends from a low of $3.72 to a high of $43.73.
Analyst ratings
85%
of 13 ratingsBuy
84.6%
Hold
15.4%
Sell
0%
People also own
Based on the portfolios of people who own COGT. This list is generated using Robinhood data, and it’s not a recommendation.